The approach to use adenovirus as a vector to deliver spike protein is similar to the approach used by the and the Russian.
Bangladesh is looking for alternative vaccine sources because India isn't supplying the vaccine according to the timeline of the deal.
As a result, rollout of vaccine has been disrupted by supply shortfalls.
A new version of the vaccine is developed twice a year as the influenza virus rapidly changes.